The importance of intellectual property rights within the biotechnology sector cannot be overstated. Innovation in this sector is a complex process and success in the early stages carries a significant level of financial risk. Securing, as well as maximising, the financial gains from innovation within the biotechnology sector through the correct deployment of intellectual property rights is therefore essential.
These are issues which the attorneys at Gill Jennings & Every fully understand. Our patent and trade mark attorneys have decades of experience developing and implementing tailored IP strategies to help ambitious and innovative biotech companies of all sizes achieve commercial success. Our clients value the intelligence and creativity of our attorneys, and the commercial approach to identifying, protecting and exploiting IP that is fundamental to our philosophy.
The strong technical expertise of our Biotech team covers all aspects of biotechnology, including:
- industrial biotechnology
- regenerative medicine
In addition to strong academic backgrounds in biosciences, our attorneys have significant industrial experience and understand the legal, technical and commercial challenges faced by companies in the global biotechnology sector. We support our clients with a complete range of IP services, including:
- invention capture
- patent drafting
- opposition and appeal
- supplementary protection certificates (SPCs)
- plant variety rights
- due diligence
- freedom to operate.
We have a long history of providing strategic advice, from assisting with developing a business plan through to ensuring IP portfolios are structured with the commercial goals in mind, be that to attract private/VC funding, secure licensing deals, float on a public market or exit via a sale. We have a track record of supporting clients preparing for IPO and we have advised on a number of successful trade sales.
Having many direct clients means that we manage the prosecution of patent applications all over the world, with the support of our network of overseas attorneys. As a result, we are experienced in navigating the legal complexities presented by the nuances of patent law in foreign jurisdictions, which can be particularly challenging in the biotechnology field. We also prosecute a large number of agency cases and help to secure and defend UK and European patent rights for international biotechnology companies.
We aim to form long-term relationships with all of our clients and to become their trusted advisors. Part of this is helping clients to establish their own internal procedures for the management of their IP. Our bespoke client portal provides access to up-to-date case data and is an invaluable tool for those managing large or complex IP portfolios.
Our Biotechnology team is a member of SuperBIO consortium, an Horizon 2020 initiative funded by the European Commission, to promote the formation of new bio-based value chains. We are also a major sponsor of Biotech & Money.